The association of blood lead level and cancer mortality among whites in the United States.

Lead is classified as a possible carcinogen in humans. We studied the relationship of blood lead level and all cancer mortality in the general population of the United States using data from the National Health and Nutrition Examination Survey II (NHANES II) Mortality Study, 1992, consisting of a total of 203 cancer deaths (117 men and 86 women) among 3,592 whites (1,702 men and 1,890 women) with average of 13.3 years of follow-up. We used Cox proportional hazard regression models to estimate the dose-response relationship between blood lead and all cancer mortality. Log-transformed blood lead was either categorized into quartiles or treated as a continuous variable in a cubic regression spline. Relative risks (RRs) were estimated for site-specific cancers by categorizing lead above and below the median. Among men and women combined, dose-response relationship between quartile of blood lead and all cancer mortality was not significant (ptrend = 0.16), with RRs of 1.24 [95% percent confidence interval (CI), 0.66-2.33], 1.33 (95% CI, 0.57-3.09), and 1.50 (95% CI, 0.75-3.01) for the second, third, and fourth quartiles, respectively, compared with the first quartile. Spline analyses found no dose response (p = 0.29), and none of the site-specific cancer RRs were significant. Among men, no significant dose-response relationships were found for quartile or spline analyses (p trend = 0.57 and p = 0.38, respectively). Among women, no dose-response relationship was found for quartile analysis (ptrend = 0.22). However, the spline dose-response results were significant (p = 0.001), showing a threshold effect at the 94th percentile of blood lead or a lead concentration of 24 microg/dL, with an RR of 2.4 (95% CI, 1.1-5.2) compared with the risk at 12.5 percentile. Because the dose-response relationship found in women was not found in men, occurred at only the highest levels of lead, and has no clear biologic explanation, further replication of this relationship is needed before it can be considered believable. In conclusion, individuals with blood lead levels in the range of NHANES II do not appear to have increased risk of cancer mortality.

[1]  Wedeen Rp.  Lead and Hypertension: Who Cares? , 2000 .

[2]  K Steenland,et al.  Lead and cancer in humans: where are we now? , 2000, American journal of industrial medicine.

[3]  O. Wong,et al.  Cancer mortality study of employees at lead battery plants and lead smelters, 1947-1995. , 2000, American journal of industrial medicine.

[4]  N. Pedersen,et al.  Both the environment and genes are important for concentrations of cadmium and lead in blood. , 2000, Environmental health perspectives.

[5]  J. LaDou.  Lead Mining Must Be Stopped , 2000, International journal of occupational and environmental health.

[6]  Edward L. Korn,et al.  Analysis of Health Surveys , 1999 .

[7]  C. Loria,et al.  Plan and operation of the NHANES II Mortality Study, 1992. , 1999, Vital and health statistics. Ser. 1, Programs and collection procedures.

[8]  E W Gunter,et al.  Exposure of the U.S. population to lead, 1991-1994. , 1998, Environmental health perspectives.

[9]  B Barnwell,et al.  SUDAAN User's Manual, Release 7.5, , 1997 .

[10]  T. Schnorr,et al.  Identifying Deaths before 1979 Using the Social Security Administration Death Master File , 1997, Epidemiology.

[11]  P Boffetta,et al.  Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. , 1995, Occupational and environmental medicine.

[12]  K. Flegal,et al.  The decline in blood lead levels in the United States. The National Health and Nutrition Examination Surveys (NHANES) , 1994, JAMA.

[13]  P. Landrigan,et al.  The mortality of lead smelter workers: an update. , 1992, American journal of public health.

[14]  L. P. Zhao,et al.  Efficiency loss from categorizing quantitative exposures into qualitative exposures in case-control studies. , 1992, American journal of epidemiology.

[15]  Y. V. von Schirnding,et al.  Blood lead levels in South African inner-city children. , 1991, Environmental health perspectives.

[16]  R. Simon,et al.  Flexible regression models with cubic splines. , 1989, Statistics in medicine.

[17]  W. Harlan.  The relationship of blood lead levels to blood pressure in the U.S. population. , 1988, Environmental health perspectives.

[18]  J L Annest,et al.  Chronological trend in blood lead levels between 1976 and 1980. , 1983, The New England journal of medicine.

[19]  J. Annest,et al.  National estimates of blood lead levels: United States, 1976-1980: association with selected demographic and socioeconomic factors. , 1982, The New England journal of medicine.

[20]  Herbert L. Needleman,et al.  Preventing lead poisoning in young children , 1978 .

[21]  Margo J. Anderson,et al.  The Census , 1921, The Hospital.

[22]  R. Wedeen.  Lead and hypertension: who cares? , 2000, International journal of occupational and environmental health.

[23]  S. Tong,et al.  [Environmental lead exposure: a public health problem with global dimensions]. , 2000, Servir.

[24]  Taylor Murray,et al.  Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.

[25]  E L Korn,et al.  Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. , 1997, American journal of epidemiology.

[26]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[27]  Welniak Ej,et al.  Money income and poverty status of families and persons in the United States: 1984 (advance data from the March 1985 Current Population Survey). , 1985, Current population reports. Series P-60, Consumer income.

[28]  J T Massey,et al.  Plan and operation of the Second National Health and Nutrition Examination Survey, 1976-1980. , 1981, Vital and health statistics. Ser. 1, Programs and collection procedures.

[29]  Chisolm,et al.  Preventing lead poisoning in young children. A statement by the Center for Disease Control. , 1978, The Journal of pediatrics.